These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3301660

  • 1. Red cell substitutes: present status.
    Sehgal LR, Sehgal HL, Gould SA, Rosen AL, DeWoskin R, Moss GS.
    Indian J Pediatr; 1987; 54(3):403-8. PubMed ID: 3301660
    [No Abstract] [Full Text] [Related]

  • 2. Polyhemoglobin and fluorocarbon as blood substitutes.
    Moss GS, Gould SA, Sehgal LR, Rosen AL, Sehgal HL.
    Biomater Artif Cells Artif Organs; 1987; 15(2):333-6. PubMed ID: 3447649
    [No Abstract] [Full Text] [Related]

  • 3. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
    Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
    [No Abstract] [Full Text] [Related]

  • 4. Clinical experience with Fluosol-DA (20%) in the United States.
    Tremper KK, Levine EM, Waxman K.
    Int Anesthesiol Clin; 1985 Feb; 23(1):185-97. PubMed ID: 3884514
    [No Abstract] [Full Text] [Related]

  • 5. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK, Anderson ST.
    Annu Rev Med; 1985 Feb; 36():309-13. PubMed ID: 3888055
    [Abstract] [Full Text] [Related]

  • 6. Current perspectives on blood substitutes.
    Gould SA, Moss G.
    Curr Surg; 1987 Feb; 44(4):279-81. PubMed ID: 3665573
    [No Abstract] [Full Text] [Related]

  • 7. The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study.
    Kagawa S, Koshu K, Yoshimoto T, Suzuki J.
    Surg Neurol; 1982 Jan; 17(1):66-70. PubMed ID: 6803373
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin].
    Vigneron C, Labrude P, Dellacherie E.
    Ann Fr Anesth Reanim; 1986 Jan; 5(3):260-8. PubMed ID: 3535579
    [Abstract] [Full Text] [Related]

  • 10. Perfluorocarbons and haemoglobin solutions: will they ever reach clinical practice?
    Lamy M, Deby-Dupont G.
    Acta Anaesthesiol Belg; 2003 Jan; 54(4):299-300. PubMed ID: 14719348
    [No Abstract] [Full Text] [Related]

  • 11. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty.
    Kerins DM.
    Am J Med Sci; 1994 Mar; 307(3):218-21. PubMed ID: 8160713
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
    Nishimura N, Hiranuma N, Sugi T.
    Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
    [Abstract] [Full Text] [Related]

  • 14. Red cell substitutes: hemoglobin solution or fluorocarbon?
    Gould SA, Rosen AL, Sehgal LR, Sehgal HL, Rice CL, Moss GS.
    J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Blood substitutes as therapy in massive surgery and trauma.
    Tye RW.
    Prog Clin Biol Res; 1982 Sep; 108():79-89. PubMed ID: 6817339
    [No Abstract] [Full Text] [Related]

  • 18. Current status of oxygen carriers ('blood substitutes'): 2006.
    Winslow RM.
    Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.